Epidemiological study on incidence, stage at diagnosis, treatment and prognosis of Merkel cell carcinoma in Japan

Epidemiological study on incidence, stage at diagnosis, treatment and prognosis of Merkel cell carcinoma in Japan - Epidemiological study of Merkel cell carcinoma in Japan

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024410

Enrollment

150

Registered

2016-10-14

Start date

2016-09-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Merkel cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with histologically confirmed Merkel cell carcinoma between January, 2005 and December, 2014 in Japan

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Prognosis of Merkel cell carcinoma	—

Secondary

Measure	Time frame
The number of patients, stage at diagnosis and types of treatments of Merkel cell carcinoma	—

Countries

Japan

Contacts

Public ContactKotaro Nagase

Saga University Division of Dermatology, Department of Internal Medicine

nagasek@cc.saga-u.ac.jp0952-34-2368

Outcome results